Author:
Blomme Arnaud,Van Simaeys Gaetan,Doumont Gilles,Costanza Brunella,Bellier Justine,Otaka Yukihiro,Sherer Félicie,Lovinfosse Pierre,Boutry Sébastien,Palacios Ana Perez,De Pauw Edwin,Hirano Touko,Yokobori Takehiko,Hustinx Roland,Bellahcène Akeila,Delvenne Philippe,Detry Olivier,Goldman Serge,Nishiyama Masahiko,Castronovo Vincent,Turtoi Andrei
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference29 articles.
1. Siolas D, Hannon GJ. Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res. 2013;73:5315–9.
2. Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012;9:338–50.
3. Giovanella BC, Stehlin JS, Wall ME, Wani MC, Nicholas AW, Liu LF, et al. DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. Science. 1989;246:1046–8.
4. Houghton JA, Maroda SJ Jr., Phillips JO, Houghton PJ. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res. 1981;41:144–9.
5. Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc. 2009;4:1670–80.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献